Top Markets
Coin of the day
Dogecoin Cash, Inc. Dogecoin Cash, Inc.

Dogecoin Cash, Inc.

DOGP
Kedudukan dalam Saham #38196
Dogecoin Cash, Inc., through its various divisions, offers online telemedicine... Dogecoin Cash, Inc., through its various divisions, offers online telemedicine referral services, enabling clients across the United States to obtain medical marijuana cards. A central offering is PrestoDoctor, a digital healthcare platform that facilitates virtual connections between individuals and licensed physicians via video conferencing for securing medical cannabis recommendations. Beyond its telehealth operations, the company is engaged in the creation of several product lines. These encompass lozenges crafted for relief, "Recover" β€” a potent, deeply penetrating therapeutic balm designed to ease discomfort in sore muscles, joints, and conditions like arthritis or back pain β€” and "Trauma Cream," a topical solution infused with a blend of cannabinoids and THC. Furthermore, Dogecoin Cash, Inc. intends to introduce high-end men's and women's fashion from various suppliers through its e-commerce site, www.cbds.com. The firm also holds intellectual property licenses pertaining to the production of medical cannabis edibles. Its business endeavors primarily target both the cannabidiol (CBD) and broader cannabis sectors. The entity, previously known as Cannabis Sativa, Inc., adopted the name Dogecoin Cash, Inc. in November 2024 and is headquartered in Mesquite, Nevada.
Harga Saham
$0.007
Modal Pasaran
$1.14M
Perubahan (1 hari)
-2.78%
Perubahan (1 tahun)
-81.13%
Negara
US
Perdagangan Dogecoin Cash, Inc. (DOGP)

Kategori

Nisbah P/B bagi Dogecoin Cash, Inc. (DOGP)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Dogecoin Cash, Inc., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Dogecoin Cash, Inc. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa